Exhibit 5.1

November 10, 2022
EVgo Inc.
11835 W. Olympic Boulevard, Suite 900E
Los Angeles, CA 90064
Ladies and Gentlemen:
We have acted as counsel to EVgo Inc., a Delaware corporation (the “Company”), with respect to certain legal matters in connection with the offer and sale from time to time (the “Offering”) by the Company of shares of the Company’s Class A Common Stock, par value $0.0001 per share (the “Securities”), with an aggregate sales price of up to $200,000,000, which may be offered and sold from time to time pursuant to the Equity Distribution Agreement, dated as of November 10, 2022 (the “Equity Distribution Agreement”), between the Company and J.P. Morgan Securities LLC, Evercore Group L.L.C. and Goldman Sachs & Co. LLC as sales agents (the “Sales Agents”), a copy of which is being filed with the Securities and Exchange Commission (the “Commission”) as an exhibit to the Company’s Current Report on Form 8-K filed on or about the date hereof. The Securities will be offered for sale pursuant to a prospectus supplement dated November 10, 2022 (the “Prospectus Supplement”), that will be filed with the Commission pursuant to Rule 424(b)(5) on or after November 10, 2022, to a prospectus dated August 25, 2022 (as amended and supplemented by the Prospectus Supplement, the “Prospectus”) that constitutes a part of the Company’s Registration Statement on Form S-3 (Registration No. 333-266753), filed with the Commission on August 10, 2022 (the “Registration Statement”), which Registration Statement was declared effective by the Commission on August 25, 2022.
In rendering the opinions set forth below, we have reviewed (i) the Equity Distribution Agreement; (ii) the Registration Statement; (iii) the Prospectus Supplement; (iv) the Prospectus; (v) the Second Amended and Restated Certificate of Incorporation of the Company, as amended; (vi) the Amended and Restated Bylaws of the Company, as amended; (vii) resolutions adopted by the Board of Directors of the Company and resolutions adopted by the Pricing Committee of the Company (the “Resolutions”) relating to the Registration Statement, the Offering, the Equity Distribution Agreement and related matters, including those resolutions authorizing the Chief Financial Officer (the “Authorized Officer”) to, among other things, effect sales under the Equity Distribution Agreement; and (vii) such other certificates, statutes and other instruments and documents as we considered appropriate for purposes of the opinions hereafter expressed. In addition, we have reviewed such questions of law as we considered appropriate. As to matters of fact relevant to the opinions expressed below, and as to factual matters arising in connection with our review of corporate documents, records and other documents and writings, we have relied upon certificates and other communications of corporate officers of the Company, without further investigation as to the facts set forth therein.